Immediate Impact
28 standout
Citing Papers
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine
2024 Standout
Works of Kurt Cooper being referenced
Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kurt Cooper | 241 | 126 | 54 | 15 | 295 | |
| Suzanne E. Wollen-Roberts | 207 | 107 | 34 | 17 | 281 | |
| Ricky Adams | 249 | 94 | 14 | 12 | 291 | |
| Beatriz Escudero-Pérez | 252 | 117 | 14 | 22 | 334 | |
| Laure R. Deflubé | 232 | 164 | 14 | 9 | 328 | |
| Susan E. Witko | 208 | 208 | 25 | 9 | 308 | |
| Amanda Phelps | 164 | 86 | 64 | 24 | 289 | |
| Jason Martin | 205 | 173 | 24 | 20 | 333 | |
| Jesse Steffens | 184 | 74 | 13 | 15 | 287 | |
| Kyle Shifflett | 170 | 76 | 9 | 13 | 233 | |
| Steve Kwilas | 214 | 53 | 23 | 7 | 273 |
All Works
Login with ORCID to disown or claim papers
Loading papers...